mrr pvt. Ltd.

Global Critical Care Therapeutics Market Size to grow at a CAGR of 3.62% Between Period 2017-2021: Recent Analysis By MarketResearchReports.Biz

Press Release   •   Feb 13, 2017 10:44 IST

The report analyzes and presents an overview on "Global Critical Care Therapeutics Market 2017-2021" worldwide.

Critical care or intensive care is the close monitoring and treatment given to individuals with acute, life-threatening illness or injuries such as shock, burns, accidents, complicated surgeries, sepsis, and severe breathing problems. It usually takes place in an ICU or trauma center. Plasma is the fluid portion of the blood, in which all the blood cells are suspended. It makes up about 55% of the total volume of the blood. The other components such as red blood cell (RBC), white blood cell (WBC), and platelets together comprise the remaining 45% of the blood. Plasma is mainly made up of water, which accounts for about 91% of the total volume.

The global critical care therapeutics market to grow at a CAGR of 3.62% during the period 2017-2021.

Covered in this report

The report covers the present scenario and the growth prospects of the global critical care therapeutics market for 2017-2021. To calculate the market size, the report considers the revenue generated from sales of critical care therapeutics was considered.

The market is divided into the following segments based on geography:

Get The Sample Copy Of This Report:

Global Critical Care Therapeutics Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

CSL Behring
Kedrion Biopharma

Other prominent vendors

Abeona Therapeutics
ADMA Biologics
Asklepios BioPharmaceutical
Aspen Pharma
Bayer HealthCare
Bio Products Laboratory
BioDelivery Sciences
Biogen Idec
Biotest Pharmaceuticals
Bristol-Myers Squibb
Catalyst Biosciences
China Biologic Products
Cosmo Pharmaceuticals
King Pharmaceuticals
Mitsubishi Tanabe Pharma
Novo Nordisk
Portola Pharmaceuticals
ProMetic Life Sciences
rEVO Biologics
Rockwell Medical
Shanghai RAAS
Teva Pharmaceutical
The Medicines Company
Thermo Fisher Scientific
Tianjin SinoBiotech & Beijing Bio-Fortune
Ventria Bioscience

Market driver

Growing preference for marketed products over alternative treatment options.
For a full, detailed list, view our report

Browse More Publihed Healthcare Market Research Reports:

Market challenge

Existence of plasma fractionation supply and demand gap.
For a full, detailed list, view our report

Market trend

Increased development of recombinant products for critical care use.
For a full, detailed list, view our report

Key questions answered in this report

What will the market size be in 2021 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analysts time when you purchase this market report. Details are provided within the report.

About us is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.

To View The Latest Industry Press Releases:

Mr. Nachiket
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-621-2074
Follow us on LinkedIn: